Lidan Zhang
Cancer Center And State Key Laboratory Of Biotherapy
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Novel FGFR Inhibitor Combined with Radiotherapy Induces GSDME-Dependent Pyroptosis to Amplify Immunogenic Cell Death Improving Anti-Tumor Activity.
Journal: Journal of medicinal chemistry
Published: December 30, 2025
Effectiveness and safety of hematoporphyrin monomethyl ether-mediated photodynamic therapy versus pulsed dye laser for port-wine stain: A retrospective study.
Journal: Journal of the American Academy of Dermatology
Published: October 22, 2025
Association of the CHG index with 90-day functional outcomes and mortality in acute ischemic stroke after endovascular therapy: A retrospective study.
Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
Published: October 01, 2025
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Retrospective Study of 51 Chinese Patients.
Journal: Clinical, cosmetic and investigational dermatology
Published: July 11, 2024
Design, synthesis and biological evaluation of novel naphthoquinothiazole derivatives as potent antitumor agents through inhibiting STAT3.
Journal: Bioorganic chemistry
Published: April 30, 2024
Chemical activation of mitochondrial ClpP to modulate energy metabolism of CD4+ T cell for inflammatory bowel diseases treatment.
Journal: Cell reports. Medicine
Published: April 23, 2024
Exploration of novel isoxazole-fused quinone derivatives as anti-colorectal cancer agents through inhibiting STAT3 and elevating ROS level.
Journal: European journal of medicinal chemistry
Published: January 10, 2024
A patent review of EZH2 inhibitors from 2017 and beyond.
Journal: Expert opinion on therapeutic patents
Published: April 25, 2023
Design, Synthesis, and Biological Evaluation of a Potent Dual EZH2-BRD4 Inhibitor for the Treatment of Some Solid Tumors.
Journal: Journal of medicinal chemistry
Published: February 12, 2023
A novel VEGFR inhibitor ZLF-095 with potent antitumor activity and low toxicity.
Journal: Heliyon
Published: December 14, 2022
Pharmacological inhibition of EZH2 by ZLD1039 suppresses tumor growth and pulmonary metastasis in melanoma cells in vitro and in vivo.
Journal: Biochemical pharmacology
Published: November 08, 2022
Discovery and SAR Study of Quinoxaline-Arylfuran Derivatives as a New Class of Antitumor Agents.
Journal: Pharmaceutics
Published: September 20, 2022
Last Updated: 09/26/2026